MTHFD2 overexpression not only facilitates cancer cell migration and invasion, but also predicts poor clinical outcomes in hepatocellular carcinoma and renal cell carcinoma.12, 13. This evidence concerns the gene MTHFD2 and renal cell carcinoma.